NCT04579835 Twin A Breech External Cephalic Version Intervention Trial (TWEXIT)
| NCT ID | NCT04579835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charite University, Berlin, Germany |
| Condition | Breech Presentation |
| Study Type | OBSERVATIONAL |
| Enrollment | 45 participants |
| Start Date | 2020-09-28 |
| Primary Completion | 2025-09-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45 participants in total. It began in 2020-09-28 with a primary completion date of 2025-09-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective study assessing the use of external cephalic version for the management of Twin A breech presentation in twin pregnancy.
Eligibility Criteria
Inclusion Criteria: * Presence of the written consent of the patients. * The patients must be over 18 years old . * No limit in the ability to consent. Exclusion Criteria: * Age under 18 * Limited ability to consent * Placenta previa * Fetal abnormalities
Contact & Investigator
Larry Hinkson, FRCOG
PRINCIPAL INVESTIGATOR
Charité University Hospital
Frequently Asked Questions
Who can join the NCT04579835 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breech Presentation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04579835 currently recruiting?
Yes, NCT04579835 is actively recruiting participants. Contact the research team at Larry.Hinkson@charite.de for enrollment information.
Where is the NCT04579835 trial being conducted?
This trial is being conducted at Mitte, Germany.
Who is sponsoring the NCT04579835 clinical trial?
NCT04579835 is sponsored by Charite University, Berlin, Germany. The principal investigator is Larry Hinkson, FRCOG at Charité University Hospital. The trial plans to enroll 45 participants.